XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2017 $ 38,940 $ 115 $ 760,225 $ (97) $ (721,303)
Balance (in shares) at Dec. 31, 2017   115,555      
Net loss (13,885)       (13,885)
Other comprehensive income (loss) (329)     (329)  
Issuance of common stock from public offering, net of offering costs 57,262 $ 15 57,247    
Issuance of common stock from public offering, net of offering costs (in shares)   14,039      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 1,295 $ 1 1,294    
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   951      
Stock-based compensation 2,315   2,315    
Balance at Mar. 31, 2018 85,598 $ 131 821,081 (426) (735,188)
Balance (in shares) at Mar. 31, 2018   130,545      
Balance at Dec. 31, 2018 84,519 $ 136 863,531 (281) (778,867)
Balance (in shares) at Dec. 31, 2018   136,853      
Net loss (18,792)       (18,792)
Other comprehensive income (loss) 211     211  
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 684 $ 2 682    
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   965      
Stock-based compensation 2,878   2,878    
Balance at Mar. 31, 2019 $ 69,500 $ 138 $ 867,091 $ (70) $ (797,659)
Balance (in shares) at Mar. 31, 2019   137,818